Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial

• Main Authors: Michael W. Simon (Author), Regine Bataille (Author), Nicole S. Caldwell (Author), Bradford D. Gessner (Author), Luis Jodar (Author), Erik Lamberth (Author), Yahong Peng (Author), Daniel A. Scott (Author), Lanyu Lei (Author), Peter C. Giardina (Author), William C. Gruber (Author), Kathrin U. Jansen (Author), Allison Thompson (Author), Wendy Watson (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTUse of pneumococcal conjugate vaccines (PCVs) has led to substantial reductions in the global burden of pediatric pneumococcal disease. Expansion of serotype coverage has been achieved by increasing PCV valency, but this may carry the potential risk of antibody interference. A complementary...